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Contribution: 
What are the novel findings of this work? 
Routine contingent screening for placenta accreta spectrum disorders based on 
the finding of placenta previa and previous uterine surgery is effective in a 
public healthcare setting. 
What are the clinical implications of this work? 
A contingent screening strategy for placenta accreta spectrum disorders is 
feasible in an ultrasound service where placenta localization is routinely 
performed. When linked to a placenta accreta diagnostic and surgical 
management service, adoption of such a screening strategy has the potential to 
significantly reduce the maternal morbidity and mortality associated with this 
condition. 
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ABSTRACT 
 
Objectives: Maternal mortality related to the placenta accreta spectrum (PAS) 
disorders remain substantial when an unexpected diagnosis is made at 
delivery. The aim of this study was to evaluate the effectiveness of a routine 
contingent ultrasound screening program for PAS.  
Methods: A retrospective study conducted between 2009 and 2019 involving 
two groups: a screening cohort of unselected women attending for routine mid-
trimester ultrasound assessment and a diagnostic cohort comprised of referrals 
to the PAS diagnostic service with a suspected diagnosis of PAS in women with 
placenta previa and previous uterine surgery. Ultrasound assessment by the 
PAS diagnostic service was comprised of two-dimensional greyscale and color 
Doppler ultrasonography, and women with a diagnosis of PAS were usually 
managed with conservative myometrial resection. The final diagnosis of PAS 
was based on a combination of intraoperative clinical findings and 
histopathological examination of the surgical specimen. 
Results: 57,179 women underwent routine mid-trimester fetal anatomy 
assessment with a third trimester diagnosis of placenta previa in 220 (0.38%). 
Seventy-five of these women were referred to the PAS diagnostic service 
because of a history of previous uterine surgery, where 21 of 22 cases of PAS 
were correctly diagnosed (sensitivity of 95.45%, 95%CI: 77.16-99.88% and 
specificity of 100%, 95%CI: 99.07-100%). Univariate analysis demonstrated that 
two or more previous Cesarean sections (OR 94.20, 95%CI 22.00-656.00) and 
placenta previa (OR 20.50, 95%CI 4.22-369.00) were the strongest risk factors 
for PAS. In the diagnostic cohort, there were 173 referrals with one false 
positive and three false negative diagnoses – resulting in a sensitivity 96.63% 
(95%CI: 90.46-99.30%) and specificity 98.81% (95%CI: 93.54-99.97%). 
This article is protected by copyright. All rights reserved.
  
Conclusion: A contingent screening strategy for PAS is both feasible and 
effective in a routine healthcare setting. When linked to a placenta accreta 
diagnostic and surgical management service, adoption of such a screening 
strategy has the potential to reduce the maternal morbidity and mortality 
associated with this condition. Larger prospective studies are necessary before 
implementing this screening strategy into routine clinical practice.
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INTRODUCTION 
 
Placental accreta spectrum (PAS) disorders are a recognized cause of major 
maternal morbidity and mortality, with a reported prevalence of between 0.01% 
to 1.1% of pregnancies 1. The incidence of PAS is increasing worldwide - 
attributed to the rising rate of cesarean section (CS) 2–5. Previous Cesarean 
birth is associated with an almost three-fold increase in risk of PAS in the next 
pregnancy compared to those with a previous vaginal delivery 6.  The main risk 
factor for PAS in the current pregnancy is a diagnosis of placenta previa, with 
more than 90% of PAS cases being associated the diagnosis of placenta previa 
combined with a previous history of uterine surgery 7–9. PAS is associated with 
a significant increase in maternal morbidity and mortality from massive 
peripartum hemorrhage 10,11. However, hemorrhagic morbidity can be 
significantly reduced when a diagnosis of PAS is made prior to admission at the 
time of delivery 12. Systematic screening and diagnosis of PAS would permit 
referral of these high-risk women to tertiary hospitals with specialized 
multidisciplinary teams experienced in the management of pregnancies 
complicated by PAS 13,14.  
 
Antenatal ultrasound diagnosis of PAS is possible with close to 90% accuracy 
in specialist referral centers with expertise in the diagnosis of PAS 15,16. 
However, the diagnostic accuracy for PAS in non-specialist referring hospitals is 
only 50% as clinical suspicion for PAS and/or knowledge of risk factors is low 
17,18. There is a clinical need for an effective and systematic screening program 
for PAS in referring hospitals, so that cases suspected with PAS can be referred 
to a PAS diagnostic center, and if confirmed, for subsequent specialist surgical 
management to prevent the maternal morbidity associated with undiagnosed 
PAS. The aim of this study is to evaluate the effectiveness of a contingent 
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screening program for identification of pregnancies with PAS based on 
persistent low-lying placenta in the third trimester in women with a history of 
previous uterine surgery or Cesarean section. 
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METHODS 
 
This is a retrospective cohort study conducted between 2009 and 2019 in the 
Fetal Medicine Unit of St George’s University Hospitals NHS Foundation Trust, 
London, UK. Two cohorts of patients were included in this study: a ‘screening 
cohort’ of unselected women attending for routine mid-trimester ultrasound 
assessment and a second ‘diagnostic cohort’ comprised of local and external 
referrals to the diagnostic service because of a suspicion of PAS. In the 
‘screening cohort’, women diagnosed to have a low-lying placenta (leading 
edge less than 2cm from the internal cervical os) at the mid-trimester fetal 
anomaly assessment were scheduled for a 32-34 week placental localization 
scan 19. At the 32-34 week assessment, placenta previa was confirmed if the 
placental leading edge was within 2 cm of the internal os 19,20. Patients with 
confirmed placenta previa with a history of previous uterine surgery or 
Caesarean section were referred to the PAS diagnostic service. Women with a 
low-lying placenta at the mid-trimester ultrasound who transferred care for 
management in another center before placental localization at 32-34 weeks 
were excluded from the analysis. 
 
All women undergoing routine ultrasound screening in pregnancy were 
assessed by qualified sonographers and any cases with fetal or maternal 
complications were managed by maternal-fetal medicine specialists. In 
particular, the PAS diagnostic service was run by two consultants (BT, AB) with 
significant experience and expertise in the prenatal diagnosis of PAS. 
Ultrasound assessment by the PAS diagnostic service was comprised of two-
dimensional (2D) grey-scale ultrasound and color Doppler ultrasonography as 
previously described 21,22. The following markers were assessed: 1) the 
presence of multiple irregular lacunar spaces within the placenta with turbulent 
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blood flow on Doppler ultrasonography (peak systolic velocity often >10 cm/s); 
2) Loss of the ‘clear zone’, the normal hypoechoic line between the placenta 
and myometrium; 3) Myometrial thinning of the retroplacental area; 4) Lower 
uterine segment placental thickness; 5) Bladder wall interruption defined as the 
loss or irregularity of the hyperechoic line between uterine serosa and bladder. 
Color Doppler was only used at discretion of the examiner and mainly to 
differentiate lacunae from placental lakes 21–23. The presence of two or more of 
ultrasound signs was considered diagnostic of PAS, one isolated sign was 
labelled as equivocal and the absence of any ultrasound signs was considered 
negative for a PAS diagnosis. Magnetic resonance imaging (MRI) was only 
performed in cases where ultrasound signs of extra-uterine invasion of the 
placenta (focal exophytic mass, distortion of cervix or parametrial anatomy) was 
suspected. Women with a diagnosis of PAS were referred to the PAS surgical 
team for further management – usually with a conservative surgical technique 
(Triple P procedure) which is recommended by the International Federation of 
Gynecology and Obstetrics (FIGO) as an alternative to peripartum hysterectomy 
14,24,25. 
 
Eligible pregnancies were identified by searching the electronic database 
(ViewPoint version 5.6.26.148, ViewPoint Bildverarbeitung GMBH, Wessling, 
Germany), review of the surgical notes and histological records. Demographic, 
surgical and histological data and obstetrical history were retrieved from the 
clinical records. The final diagnosis of PAS was based on intraoperative clinical 
findings and histopathological examination of the surgical specimen 26. A 
histological diagnosis of placenta accreta, increta and percreta were only 
possible when hysterectomy or partial myometrial resection specimens were 
accessible for examination. If a histological specimen was not available, the 
final PAS diagnosis was based on the surgical record of adherent placenta. 
Ethics approval and signed patient consent was not required as per the UK 
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Health Regional Authority (HRA) decision tool. The findings of this study were 
reported in agreement with the STROBE Statement 27. 
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Statistical analysis 
Comparisons between continuous and categorical variables were performed 
using Kruskall-Wallis test for the former and χ2-square or Fisher’s exact test for 
the latter. Univariate binomial logistic regression analysis was carried out to 
determine which risk factors were associated with PAS in women with placenta 
previa in the screening cohort. Due to the limited number of PAS cases, forward 
stepwise multivariable logistic regression analysis was performed to determine 
which factors identified in univariate analysis contributed to the prediction of 
PAS in women with placenta previa and previous Cesarean section. All data 
analyses were carried out using the statistical software package R version 4.0.1 
(2020-06-06) and MedCalc for Windows, version 19.4.1 (MedCalc Software, 
Ostend, Belgium). Statistical significance was defined as a p value <0.05. 
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RESULTS 
 
Screening Cohort 
A total of 57,179 women underwent routine mid-trimester fetal anatomy 
assessment at 18 to 23 weeks’ gestation between 2009 and 2019. Among the 
4486 (7.8%) women with a repeat scan scheduled for a low-lying placenta, a 
total of 415 (9.2%) had a diagnosis of low-lying placenta at 32-34 weeks’ 
gestation (Figure 1). A total of 220 women had a final diagnosis of placenta 
previa at subsequent scan assessments, and 75 (34.1%) of these women were 
referred to the PAS diagnostic service because of a history of previous uterine 
surgery. This final cohort contained 22 cases of PAS, of whom 21 cases were 
correctly identified by the PAS diagnostic service and managed surgically 
(Supplementary Table). Additionally, there were five women who were followed 
up serially from the first trimester for a diagnosis of scar implantation who 
underwent emergency delivery before 32 weeks’ gestation and a further case of 
focal PAS in the non-placenta previa cohort in a woman with a previous 
myomectomy. The overall performance of a contingent PAS screening program 
where women with a diagnosis of placenta previa and previous uterine surgery 
are referred to a specialist PAS diagnostic service was: sensitivity 95.45% 
(95%CI: 77.16-99.88%), specificity of 100% (95%CI: 99.07-100%) with a 
99.75% (95%CI: 98.30-99.96%) negative predictive value and 100% (95%CI: 
not calculable) positive predictive value. 
 
The demographic characteristics and risk factors for women with a low-lying 
placenta in the third trimester who had confirmed PAS or no evidence of 
abnormal placental invasion are shown in Table 1. Univariate analysis 
demonstrated that multiparity >2 (OR 35.50, 95%CI 6.90-649.00), two or more 
previous Cesarean sections (OR 94.20, 95%CI 22.00-656.00) and placenta 
previa (OR 20.50, 95%CI 4.22-369.00) were the strongest risk factors for PAS. 
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Smoking (OR 1.12, 95%CI 0.06-5.92), body mass index >24kg/m2 (OR 1.04, 
95%CI 0.95-1.11) and other previous uterine surgeries (OR 3.49, 95%CI 0.77-
11.60) were not associated with PAS in this cohort. Paired stepwise multivariate 
logistic regression demonstrated that the strongest risk factors beyond the 
number of previous Cesarean section were variables related to placental 
localization and ethnicity (Table 2). Maternal age, Asian ethnicity and multiparity 
were no longer associated with an increased risk of PAS after controlling for the 
number of previous Cesarean section. 
 
Diagnostic Cohort 
There were 173 (local 99 and referred 74) suspected cases of PAS referred to 
the diagnostic service between 2009 and 2019 (Figure 2). There was one false 
positive and three false negative diagnoses of PAS in this cohort. The overall 
performance of the PAS diagnostic service was: sensitivity 96.63% (95%CI: 
90.46-99.30%), specificity 98.81% (95%CI: 93.54-99.97%), positive likelihood 
ratio 81.17 (95%CI: 11.56-569.76) and negative likelihood ratio 0.03 (95%CI: 
0.01-0.10). 
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DISCUSSION 
 
Routine contingent screening for PAS based on the finding of placenta previa in 
the third trimester and a history of previous Cesarean section is both feasible 
and effective. The ability of such a screening program to result in improved 
clinical outcomes is contingent on access to a multidisciplinary PAS diagnostic 
and surgical service. 
 
Comparison with other studies 
The prevalence of placenta previa (0.4%) and PAS (0.04%) in our screening 
cohort are consistent with what has been previously described in a meta-
analysis of population-based studies of 0.56% for placenta previa and 0.07% for 
PAS – consistent with the assertion that the study was performed on a routine 
pregnancy population 28. The finding that number of previous Cesarean 
sections and diagnosis of placenta previa were the most important risk factors 
for PAS are consistent with the reports from previous systematic reviews of 
PAS 1,6,7. Even one previous Cesarean section increased the odds for PAS by 
over 25-fold in a cohort of women with placenta previa and the majority of PAS 
cases in our cohort had only one previous Caesarean section. Other uterine 
surgeries were not associated with PAS in this cohort, in contrast to the findings 
in some previous studies 29,30. It is difficult to conclude whether the lack of an 
association between other uterine surgery and PAS is a consequence of the 
small number of cases or a true finding in this study 30,31. 
 
Afro-Caribbean ethnicity remained associated with PAS even after statistical 
correction for previous Cesarean section. This finding has not been previously 
reported and might be explained either by socio-economic determinants of 
health in black and minority ethnic populations, or more likely, from residual 
confounding from the relatively low number of patients with PAS in the 
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screening cohort and the increased likelihood for Cesarean birth in Afro-
Caribbean women. 
 
Despite general consensus amongst international guidelines that women with 
previous uterine surgery and low-lying placenta are at increased risk of PAS, 
there has been no previous systematic evaluation of the effectiveness of such a 
contingent screening program 9,21. A first trimester screening strategy for PAS 
based on the identification of low-lying placenta in women with previous uterine 
surgery between 11 and 13 weeks has been described 32. Although the benefits 
of such early screening would be to provide women with an option to have a 
first trimester abortion, the drawbacks are number of additional follow-up visits 
and low specificity resulting in high volume referrals to a PAS diagnostic 
service. The contingent screening described in the current study does not 
require additional routine scan visits and still resulted in high PAS detection. 
The SGH PAS diagnostic service correctly identified 86 out of 89 cases of PAS 
using ultrasound alone resulting in sensitivity and specificity of greater than 
95%, which are superior to retrospective studies (sensitivity 88%, 95%CI 81.0-
93.0; specificity 90%, 95%CI 88.0-93.0) and comparable to prospective 
diagnostic studies (sensitivity 97%, 95%CI 93.0-99.0; specificity 97%, 95%CI 
97.0-98.0) 9. 
 
Clinical Implications 
Effective prenatal screening that correctly identifies pregnancies complicated by 
PAS would significantly improve maternal outcomes due to scheduled birth in a 
center with tertiary level facilities specialized in PAS care 12. The need for such 
screening is compounded by the continuing global trend for an increase in both 
Cesarean section rates and PAS disorders 33. We have shown that contingent 
screening for PAS in women with previous Cesarean section and a current 
diagnosis of placenta previa is both feasible and effective. This screening and 
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triage strategy is possible in lower-resource medical settings with basic obstetric 
ultrasound facilities and does not require additional visits beyond those that are 
indicated routinely. The success of such a screening program depends on 
access to both a specialized PAS diagnostic service with experienced operators 
and a management service at a tertiary level hospital where, if the diagnosis of 
PAS is confirmed, safe delivery can be arranged 34. 
 
Strengths and Limitations 
The major strengths of the present study are related to the relevant sample size 
in both the screening and diagnostic cohorts. Additionally, significant expertise 
has been combined with a robust surgical service with distinctive skills in the 
conservative management of PAS to allow linkage of antenatal ultrasound 
findings with surgical and histological records. The Triple P procedure used 
includes myometrial excision alongside preservation of the uterus and allows a 
full histological diagnosis in the majority of cases 26. 
 
An obvious limitation is the retrospective nature of the study and there is a need 
to validate these findings in prospective studies set in populations with variable 
Cesarean section rates in order to ensure validity in a wide range of settings. 
The absolute number of cases affected by PAS in the screening cohort was 
small, and as a consequence, it was not possible to undertake a detailed 
analysis of risk factors in the prediction of PAS. Finally, our screening protocol 
failed to detect focal PAS following myomectomy because PAS was evident 
despite the placenta being clear of the lower uterine segment. 
 
Conclusions 
A screening program for PAS based on the identification of women with 
persistent placenta previa in the third trimester and a history of previous 
Cesarean section was both feasible and highly effective. This contingent 
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strategy has the potential to improve antenatal PAS detection rates and 
decrease maternal morbidity and mortality related to undiagnosed PAS. 
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FIGURE LEGENDS 
 
Figure 1. Patient flowchart of the routinely screened cohort, where women with 
a diagnosis of placenta previa and a history of previous uterine surgery were 
referred to the placenta accreta spectrum diagnostic service for further 
management. 
 
Figure 2. Patient flowchart of the referred cohort showing the diagnostic 
accuracy of the placenta accreta spectrum service. 
 
 
Supplementary Table 1. Description of the findings in women with placenta 
accreta spectrum (PAS) assessed in the screening study
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Table 1. Comparison of risk factors and univariate analysis for confirmed versus unconfirmed diagnosis of placenta accreta spectrum 
(PAS) disorders in women with a diagnosis of low-lying placenta in the third trimester of pregnancy. Data shown as median (IQR), number 
(%), odds ratio (OR) and 95% confidence interval (95% CI). *Reference: 35 years, #Reference: 24Kg/m2. 
Variable No PAS 
(n=393) 
PAS 
(n=22) 
OR (95%CI) p value 
Maternal age* (years) 35.0 (32.0-38.0) 39.0 (35.0-40.7) 1.11 (1.02-1.21) 0.018 
Ethnicity     
Caucasian 243 (61.8) 3 (13.6) Reference  
Asian 94 (23.9) 6 (27.3) 5.17 (1.34-24.90) 0.022 
Afro-Caribbean 46 (11.7) 11 (50.0) 19.40 (5.79-88.10) <0.001 
Smoking 16 (4.1) 1 (4.5) 1.12 (0.06-5.92) 0.913 
Assisted conception 62 (15.8) 0 (0.0) - - 
Body mass index# (Kg/m2) 24.2 (21.9-27.6) 25.9 (22.9-28.3) 1.04 (0.95-1.11) 0.368 
Parity     
0 180 (45.8) 1 (4.6) Reference  
1 142 (36.1) 7 (31.8) 8.87 (1.55-167.00) 0.042 
2 or more 71 (18.1) 14 (63.6) 35.50 (6.90-649.00) <0.001 
Previous Cesarean section     
0 314 (79.9) 2 (9.1) Reference  
1 64 (16.3) 11 (50.0) 27.00 (7.03-177.00) <0.001 
2 or more 15 (3.8) 9 (40.9) 94.20 (22.00-656.00) <0.001 
Previous pre-labor Cesarean section 35 (9.1) 8 (47.1) 8.89 (3.16-24.70) <0.001 
Previous intrapartum Cesarean section 36 (9.4) 7 (41.2) 6.79 (2.34-18.80) <0.001 
Previous other uterine surgery 17 (4.3) 3 (13.6) 3.49 (0.77-11.60) 0.061 
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Table 2. Paired stepwise multivariable logistic regression analysis of risk factors for placenta accreta spectrum disorders in women with a 
diagnosis of low-lying placenta in the third trimester of pregnancy. Data shown as odds ratio (OR) and 95% confidence interval (95% CI) 
for risk factors in addition to previous Cesarean section. 
Variable OR (95%CI) p value 
Number of previous Cesarean section   
One previous 23.88 (6.16-157.49) <0.001 
Two or more previous 90.33 (20.93-631.93) <0.001 
Previous Cesarean sections and…   
Maternal age (years) 1.08 (0.98-1.20) 0.11 
Asian 4.16 (0.98-21.39) 0.06 
Afro-Caribbean 17.37 (4.54-87.93) <0.001 
Para 1 0.70 (0.02-19.31) 0.809 
Para 2 or more 2.56 (0.10-66.77) 0.513 
Placenta covering the internal cervical os 20.32 (5.19-139.06) <0.001 
Placenta within 2cm of the internal cervical os 17.59 (3.35-236.74) 0.007 
Anterior placenta 12.35 (4.04-47.65) <0.001 
 
Fibroids 21 (5.3) 3 (13.6) 2.80 (0.62-9.07) 0.119 
Placenta covering internal cervical os 128 (32.6) 20 (90.9) 20.70 (5.92-231.00) <0.001 
Placenta within 2cm of internal cervical os 199 (50.6) 21 (95.5) 20.50 (4.22-369.00) 0.030 
Anterior placenta at last scan 91 (23.2) 18 (81.8) 14.90 (5.41-52.70) <0.001 
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415 (0.7%) with persistent low-lying
placenta at 32 weeks
220 (0.4%) placenta previa
75 previous uterine surgery
195 placenta >2cm from internal os
145 no previous uterine surgery
21 PAS
PAS (n=0)
PAS SERVICE
PAS (n=1)
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True +ve
(n=86)
False +ve
(n=1)
True -ve
(n=83)
False -ve
(n=3)
PAS diagnosed (n=87) No PAS diagnosed (n=86)
Women referred for suspicion of PAS (2009-2019)
Cases assessed by PAS diagnostic service (n=173)
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